US Department of Health and Human Services (HHS) purchases GSK’s A (H1N1) influenza antigen and proprietary adjuvant system
GSK announced HHS has placed initial orders for H1N1 vaccine antigen and proprietary adjuvant system, AS03.
Read the full articleYou might also wanna read
Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine
French pharmaceutical company Sanofi has offered to state publicly that a rival flu vaccine is as effective as its own, EU antitrust regula
HHS Ends mRNA Vaccine Development Under BARDA Following Review
HHS announced the beginning of a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and
hhs.gov·11mo ago
UK Health Security Agency Publishes 2025 Health Security Risk Assessment
The Health Security Risk Assessment (HSRA) is the UK Health Security Agency (UKHSA)’s assessment characterising a selection of the most sign
gov.uk·28d ago
Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses
A Stanford University team have tested their nasal spray vaccine in animals but still need to do human clinical trials.
bbc.com·4mo ago
UK Health Security Agency: Over 25% Chance of New Pandemic Within 5 Years
Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.
mdsc.pe·16d ago
Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
Stanford Medicine researchers and their colleagues invented a new vaccine that protects mice from respiratory viruses, bacteria and allergen
med.stanford.edu·4mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.